Early glycaemic exposure and cancer risk in people with newly diagnosed type 2 diabetes
Xinge Zhang, Aimin Yang, Hongjiang Wu, Eric S. H. Lau, Mai Shi, Baoqi Fan, Elaine Chow, Alice P. S. Kong, Juliana C. N. Chan, Ronald C. W. Ma, Andrea O. Y. Luk · 2026
Read Early glycaemic exposure and cancer risk in people with newly diagnosed type 2 diabetes by Xinge Zhang, Aimin Yang, Hongjiang Wu, Eric S. H. Lau, Mai Shi, Baoqi Fan, Elaine Chow, Alice P. S. Kong, Juliana C. N. Chan, Ronald C. W. Ma, Andrea O. Y. Luk (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13424208.txt.
Description
Zhang and co-authors analyzed 52,926 Hong Kong Chinese adults with newly diagnosed type 2 diabetes to test whether blood sugar levels in the first years after diagnosis shape later cancer risk. They modeled HbA1c, a blood marker averaging glucose over months, across the whole follow-up and within specific early windows after diagnosis.
Among 49,978 people in the main analysis, 1,758 developed cancer during the study period. Each 1 percent rise in time-weighted average HbA1c came with a 27 percent relative increase in cancer risk at any site. Averaging 7.0 percent or higher within the first two years meant a 30 to 75 percent higher risk, depending on the category, even after accounting for later levels. Cutting HbA1c by 1 percent at one to two years was linked with 6 percent lower risk, while later reductions showed no benefit.
Catalog record
| CREATOR | Xinge Zhang, Aimin Yang, Hongjiang Wu, Eric S. H. Lau, Mai Shi, Baoqi Fan, Elaine Chow, Alice P. S. Kong, Juliana C. N. Chan, Ronald C. W. Ma, Andrea O. Y. Luk |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |